Detalhe da pesquisa
1.
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.
Cell
; 187(2): 446-463.e16, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242087
2.
Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma.
Mod Pathol
; 37(6): 100488, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588881
3.
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Acta Neuropathol
; 147(1): 3, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38079020
4.
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
Acta Neuropathol
; 144(4): 747-765, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945463
5.
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
Genes Dev
; 23(18): 2152-65, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19759263
6.
Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
Acta Neuropathol
; 137(5): 851-854, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877433
7.
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
Neuro Oncol
; 26(4): 640-652, 2024 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141254
8.
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
Neuro Oncol
; 26(2): 335-347, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758193
9.
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Sci Rep
; 14(1): 6362, 2024 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493204
10.
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961484
11.
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
J Clin Oncol
; 41(11): 2029-2042, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599113
12.
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
Neuro Oncol
; 24(4): 639-652, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653254
13.
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications.
Neuro Oncol
; 24(9): 1471-1481, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287169
14.
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.
Clin Cancer Res
; 28(13): 2898-2910, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511927
15.
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
J Clin Invest
; 132(3)2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882581
16.
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
Neuro Oncol
; 23(11): 1872-1884, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823014
17.
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas.
Neuro Oncol
; 22(10): 1516-1526, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319527
18.
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
JAMA Oncol
; 6(4): 495-503, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027343
19.
The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
Cancer Res
; 67(4): 1626-35, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308103
20.
TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.
Cancer Res
; 75(15): 3167-80, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26001956